Display options
Cite
Sahajpal NS, Chaubey A, Goel RK, et al. Diabetic retinopathy: how far are we from personalized medicine?. Future Med Chem. 2018;10(19):2249-2252doi: 10.4155/fmc-2018-0233.
Sahajpal, N. S., Chaubey, A., Goel, R. K., & Jain, S. K. (2018). Diabetic retinopathy: how far are we from personalized medicine?. Future medicinal chemistry, 10(19), 2249-2252. https://doi.org/10.4155/fmc-2018-0233
Sahajpal, Nikhil Shri, et al. "Diabetic retinopathy: how far are we from personalized medicine?." Future medicinal chemistry vol. 10,19 (2018): 2249-2252. doi: https://doi.org/10.4155/fmc-2018-0233
Sahajpal NS, Chaubey A, Goel RK, Jain SK. Diabetic retinopathy: how far are we from personalized medicine?. Future Med Chem. 2018 Oct 01;10(19):2249-2252. doi: 10.4155/fmc-2018-0233. Epub 2018 Sep 14. PMID: 30215275.
Copy Download .nbib Format: NLM
Share it on

Future Med Chem. 2018 Oct 01;10(19):2249-2252. doi: 10.4155/fmc-2018-0233. Epub 2018 Sep 14.

Diabetic retinopathy: how far are we from personalized medicine?.

Future medicinal chemistry

Nikhil Shri Sahajpal, Alka Chaubey, Rajesh Kumar Goel, Subheet Kumar Jain

Affiliations

  1. Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, India.
  2. Head of Cytogenomics, Global Laboratory Services, Perkin Elmer, Waltham, MA, USA.
  3. Department of Pharmaceutical Sciences & Drug Research, Punjabi University, Patiala, India.

PMID: 30215275 DOI: 10.4155/fmc-2018-0233

[No abstract available.]

Keywords: artificial intelligence; characterization; diabetic retinopathy; diagnosis; genomics; imaging; personalized treatment; proteomics

MeSH terms

Publication Types